1. Introduction {#sec1}
===============

Seaweeds are considered as an economically valuable natural resource and a rich source of extraordinary therapeutic agents that are important in the pharmaceutical industry ([@bib24]). However, the available information and scientific data with regards to the medicinal potential of these plants is lacking with. Therefore, many studies have been conducted to evaluate the toxicity of medicinal plants as an initial step before investigating other therapeutic potentials of any natural extract ([@bib11]; [@bib105]). Phytochemical screening is a process of evaluating phytochemical constituents present in the natural extracts using standard established tests ([@bib10]; [@bib74]; [@bib84]). Currently, several studies have been conducted to investigate the therapeutic value of seaweeds and pointed marine algae as an outstanding source of active biochemical compounds ([@bib112]). Biological resources including seaweed may contain toxic compounds and the evaluation of cytotoxicity is required prior to focusing on any other activity. The cytotoxic effect can be evaluated *in-vitro* or *in-vivo* ([@bib16]). Brine shrimp (*Artemia* sp.) lethality assay could be used as an indicator for presence of general toxic compounds in an extract. Since this is a low cost and relatively easy assay, cytotoxicity of the aqueous extracts could be screened efficiently ([@bib67]; [@bib34]). Based on the ability to inactivate laboratory hatched brine shrimp (*Artemia* sp.) nauplii by cytotoxic compounds, brine shrimp lethality assay was proposed by [@bib16]. This method has been introduced as a safe, practical and economically cheap method used to determine bioactive and cytotoxic effect of synthetic compounds ([@bib6]). MTT assay was conducted to assess the cytotoxicity effect of seaweed extracts against mouse fibroblasts cell line (L929) ([@bib75]). The scratch wound healing assay has been broadly adapted and modified to study the effects of a variety of experimental conditions on cell migration and proliferation. In a typical scratch wound healing assay, many factors that alter the motility and/or growth of the cells can lead to increase or decrease in the rate of "healing" the gap ([@bib75]).

Wound healing is a specific process leading to the restoration of injured tissues ([@bib14]). In the past, without any theoretical knowledge, human beings have been using many plant resources based on experiential observations for the treatment of wounds, cuts, and burns ([@bib103]). In general, wound healing is a dynamic process that can be divided into five overlapping phases: hemostasis, inflammation, migration, proliferation and maturation ([@bib98]). In wound healing, TGF-β1 expression is important for inflammation, angiogenesis, re-epithelialization, and connective tissue regeneration. With the onset on an injury, cytokine expression levels are shown to be increased ([@bib90]; [@bib91]). TGB-β1, produced by macrophages, T cells and platelets is a potent stimulus of fibroblasts and involve in a critical role in the proliferative stage ([@bib32]). It is also interesting to note that once the wound field is sterilized, TGF-b1 may be able to deactivate superoxide production from macrophages *in-vitro*. This helps to protect the surrounding healthy tissue and prepare the wound for granulation tissue formation ([@bib92]). In superficial skin wounds, TGF-β stimulates contractile response and control the orientation of collagen fibers ([@bib27]). The current wound healing drugs are not satisfactory, due to their low availability, high cost and numerous detrimental side effects (allergic reaction, damage skin integrity, etc.) ([@bib42]). Almost all the wound healing processes are found to be affected by bioactive compounds isolated from natural resources such as tannins, alkaloids, and triterpenoids ([@bib42]; [@bib63]). Since seaweeds have shown several biological activities including wound healing, seaweeds have a great potential to be used to extract new therapeutic compounds. The available information on the medicinal potential of Sri Lankan seaweeds is not corroborated with creditable scientific data. For this reason, the present study was carried out to examine the phytochemical constituents, *in-vivo* and *in-vitro* cytotoxic effect and wound healing ability aqueous extracts of different seaweed species available in Sri Lanka.

2. Materials and methods {#sec2}
========================

2.1. Seaweeds sample collection {#sec2.1}
-------------------------------

Twenty-three different seaweeds species, belonging to Phaeophyta (Brown), Chlorophyta (Green) and Rhodophyta (Red) samples were collected from inter-tidal and sub-tidal habitat in Southern, Northern and North-western coastal areas in Sri Lanka (see [Figure 1](#fig1){ref-type="fig"}).Figure 1Map of seaweed samples collection location. 01-Ahangama (N 05⁰ 58.006′ E 080⁰ 22.482′), 02-Thalpe (N 05⁰ 59.792′ E 080⁰ 16.898′), 03-Chilaw (N 07⁰ 36.220′ E 079⁰ 47.120′), 04-Negambo (N 07⁰ 12.170′ E 079⁰ 48.570′), 05-Kankasanthurai (N 09⁰ 48.592′ E 080⁰ 02.546′), 06-Point Pedro (N 09⁰ 49.501′ E 080⁰ 15.119′).Figure 1

Firstly, the harvested seaweed samples were washed thoroughly with seawater (at the site), then with tap water (fresh water) to remove contaminants (sand particles, impurities and epiphytes) and finally, cleaned with distilled water. All those cleaned samples were transported to the laboratory at the Department of Veterinary Pathobiology, Faculty of Veterinary Medicine and Animal Science, University of Peradeniya, Sri Lanka under sterilized and cold conditions. Collected seaweed species were identified using identification guide ([@bib20]). Furthermore, the seaweed species were authenticated using the "Peradeniya Royal Botanical Gardens: National Herbarium in Sri Lanka" and a voucher herbarium of seaweeds ([Figure 2](#fig2){ref-type="fig"}) were deposited in the laboratory for future reference. The samples of seaweeds were dried, at 40 °C for four days until a constant weight was achieved. Then the samples were ground (Electrical Herbal Grinder; CS-700, China) to a 0.5 mm particle size powder and stored in the freezer at -20 °C (see [Table 1](#tbl1){ref-type="table"}).Figure 2Voucher specimens. SW01-*Ulva lactuca*, SW02-*Caulerpa racemosa,* SW03-*Gracilaria corticata*, SW0-*Padina antillarum,* SW05-*Sargassum illicifolium*, SW06-*Sargassum polycystem,* SW07-*Halimeda opuntin,* SW08-*Caulerpa racemosa,* SW09-*Turbinaria ornata*, SW10-*Caulerpa sertularioides,* SW11-*Stoechospermum polypodioides,* SW12-*Sargassum illicifolium*, SW13-*Sargassum illicifolium*, SW14-*Gracilaria corticata*, SW15-*Padina antillarum,* SW16-*Ulva lactuca,* SW17-*Acanthophora spicifera,* SW18-*Gelidiopsis variabilis,* SW19-*Gracilaria corticata*, SW20-*Chaetomorpha antennina*, SW21-*Chaetomorpha crassa*, SW22-*Jania adhaereus,* SW23-*Sargassum illicifolium.*Figure 2Table 1Name of Seaweed species, collected location and voucher numbers.Table 1Collect DateVoucher numberTypeSpecies NameLocationGPS Point18/02/2016SW 01Green*Ulva lactuca*ThalpeN 05⁰ 59.792′ E 080⁰ 16.898′18/02/2016SW 02Green*Caulerpa racemosa*AhangamaN 05⁰ 58.006′ E 080⁰ 22.482′18/02/2016SW 03Red*Gracilaria corticata*AhangamaN 05⁰ 58.006′ E 080⁰ 22.482′18/02/2016SW 04Brown*Padina antillarum*AhangamaN 05⁰ 58.006′ E 080⁰ 22.482′18/02/2016SW 05Brown*Sargassum ilicifolum.*ThalpeN 05⁰ 59.792′ E 080⁰ 16.898′24/02/2016SW 06Brown*Sargassum polycystem*Point PedroN 09⁰ 49.501′ E 080⁰ 15.119′24/02/2016SW 07Green*Halimeda opuntin*KankasanthuraiN 09⁰ 48.592′ E 080⁰ 02.546′24/02/2016SW 08Green*Caulerpa racemosa*Point PedroN 09⁰ 49.501′ E 080⁰ 15.119′24/02/2016SW 09Brown*Turbinaria ornata*KankasanthuraiN 09⁰ 48.592′ E 080⁰ 02.546′24/02/2016SW 10Green*Caulerpa sertularioides*KankasanthuraiN 09⁰ 48.592′ E 080⁰ 02.546′24/02/2016SW 11Brown*Stoechospermum polypodioides*Point PedroN 09⁰ 49.401′ E 080⁰ 14.593′24/02/2016SW 12Brown*Sargassum ilicifolum*KankasanthuraiN 09⁰ 48.592′ E 080⁰ 02.546′18/03/2016SW 13Brown*Sargassum ilicifolum*NegamboN 07⁰ 12.170′ E 079⁰ 48.570′18/03/2016SW 14Red*Gracilaria corticata*NegamboN 07⁰ 12.170′ E 079⁰ 48.570′18/03/2016SW 15Brown*Padina antillarum*NegamboN 07⁰ 12.170′ E 079⁰ 48.570′18/03/2016SW 16Green*Ulva lactuca*NegamboN 07⁰ 12.170′ E 079⁰ 48.570′18/03/2016SW 17Red*Acanthophora spicifera*NegamboN 07⁰ 12.170′ E 079⁰ 48.570′18/03/2016SW 18Red*Gelidiopsis variabilis*ChilawN 07⁰ 36.220′ E 079⁰ 47.120′18/03/2016SW 19Red*Gracilaria corticata*ChilawN 07⁰ 36.220′ E 079⁰ 47.120′18/03/2016SW 20Green*Chaetomorpha antennina*ChilawN 07⁰ 36.220′ E 079⁰ 47.120′18/03/2016SW 21Green*Chaetomorpha crassa*ChilawN 07⁰ 36.220′ E 079⁰ 47.120′18/03/2016SW 22Red*Jania adhaereus*ChilawN 07⁰ 36.220′ E 079⁰ 47.120′21/01/2017SW 23Brown*Sargassum ilicifolum*AhangamaN 05⁰ 58.006′ E 080⁰ 22.482′

2.2. Preparation of extracts and estimation of the concentration of seaweed extract {#sec2.2}
-----------------------------------------------------------------------------------

The powdered samples were weighed and 5 g of each sample was suspended/dissolved separately in 25 ml of distilled water. Then the samples were dissolved via sonication for 1 h using ultrasound sonicator (Branson 2510; Danbury, USA). The temperature was maintained at 40 °C throughout the process. Then, the samples were shaken in a roller overnight at room temperature (DENLEY-SPIRAMIX 5, UK) and the extracts were centrifuged (Beckman Avanti, UK) at 15000 rpm for 10 min at 4 °C and supernatants were taken for further analysis. Following methods (A and B) were used to calculate the concentrations of aqueous seaweed extracts.(A).All the residuals removed during the process of water extraction was taken and kept in 40 °C dry oven until it gives constant weight. Then the concentration was analyzed using the following equation$$\text{Concentration}{(\text{mg/ml})}\  = \frac{\text{Initial~weight~}(5\text{~g}) - \text{Weight~of~residuals}}{\text{Total~volume~}(25\text{~ml})}$$(B).5 ml of each seaweed extract was added to petri dishes separately and labeled. The extract was kept in the dryer at 40 °C temperature until the samples gets a constant weight. Finally, dry weights of the samples were recorded and concentrations were calculated as the concentration per 1 ml of the extract.

2.3. Preliminary phytochemical screening {#sec2.3}
----------------------------------------

Seaweeds contain many chemical constituents which are therapeutically active or inactive such as carbohydrates, triterpenoids, alkaloids, glycosides, tannins, flavonoids, lipids and other similar secondary metabolites ([@bib93]). Based on the literature, aqueous extraction product mainly includes high hydrophilic compounds, metals, ions, and water soluble proteins/enzymes, glycoproteins, amino acids, peptides, nucleotides, sugars, and polysaccharides ([@bib15]). Several methods were followed to screen specific compounds in the seaweed extracts of this study.

2.4. Brine shrimp lethality assay (BSLA) {#sec2.4}
----------------------------------------

BSLA assay has been noted as a useful tool for the isolation of bioactive compounds from plant extracts ([@bib72]). The assay was conducted according to [@bib73] with some modifications. Filtered, seawater (pH range; 7.85 ± 0.5) was put in a small plastic container (hatching chamber) with a partition for dark (covered) and light areas. Brine Shrimp eggs (0.5 g) were added into the dark side of the chamber. The eggs were hatched for 24--36 h at room temperature with strong aeration under continuous light regime. Then, the phototropic nauplii were collected from the illuminated side of the jar. 10--15 brine shrimp nauplii with 50 μl of seawater were added to into each well of 96 well plate filled with different concentrations (Two-fold dilution series was made separately in 96 well plates) of seaweed extracts. Distilled water was used as the negative control and the absolute ethanol was used as positive control. Well plates were incubated for 24 h and after 24 h incubation number of dead and survived shrimp nauplii were counted under the light microscope and recorded. The brine shrimps that did not show any movement for more than 2 min were recorded as dead nauplii. The percentage mortality (%M) was calculated by dividing the number of dead nauplii by the total number, and then multiplied by 100. These values were used to calculate LC~50~ values of each aqueous seaweed extract against brine shrimp. To certify that the mortality detected in the bioassay is due to the effect of the bioactive compounds present in seaweed sample and not due to starvation ([@bib96]), mortality rate of nauplii in both negative and positive control was compared with the mortality rate of seaweed treated nauplii. Cytotoxicity of seaweed extracts was evaluated by comparing the LC~50~ values.

*2.5*. *In-vitro* assay {#sec2.5}
-----------------------

### 2.5.1. Cell viability (MTT assay) {#sec2.5.1}

The mouse fibroblasts cell line (L929, ATCC, USA) was maintained at Roswell Park Memorial Institute (RPMI-1640) medium (Invitrogen, Gibco, UK), supplemented with 10 ml/L Penicillin-Streptomycin (PSA), 2 g/L sodium bicarbonate (NaHCO₃), 5 ml/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 10% fetal bovine serum (FBS, Invitrogen, Gibco, UK). L929 cells were cultured and maintained under an atmosphere of 5% CO~2~ and 95% air incubator (MCO-20AIC, Japan) at 37 °C. The cells were grown in 96-well flat bottom plates (Corning Glass-work, NY) at a density of approximately 2×10^5^ cells/well and incubated until it reaches 70%--80% confluence level. The medium was removed from the wells and washed with Phosphate buffered saline to remove the dead cells. 50 μl of RPMI medium, separately supplemented with aqueous extracts of all seaweeds samples was introduced per well plated with L929 cells. Ten dilutions of a two-fold serial dilution were used with triplicates and diluent in 8-wells were used for respectively concentration. The treated cells were incubated further for 24 h. In addition, positive and negative control tests were also prepared using absolute ethanol and distilled water, separately. After 24 h, the treated mixtures were removed and washed with PBS to remove any residual traces of chemicals. 10 μl of MTT (5 mg/ml in PBS) regent was added to each well and further incubated for 4 h at 37 °C. Finally, the formazan crystals were dissolved in 100 μl Dimethyl Sulfoxide (DMSO) and the absorbance values was measured on ELISA reader (Muitiskan Ex, German) at 570 nm ([@bib113]). All experiments were carried out in triplicates and the same experiment was conducted three times and the mean values of all experiments were analysed.

### 2.5.2. Scratch wound healing assay {#sec2.5.2}

The scratch assay was performed to study cell migration and proliferation ability with respect to the treatments. Mouse fibroblast (L929) cells were grown in RPMI-1640 supplemented with 10% FBS. 2×10^5^ cells/well were seeded into 24-well cell culture plates and incubated for 24 h, till the wells reach 70--80% confluence as a monolayer. Without changing the medium, cellular monolayer scratched with 200 μl pipette tip and an artificial linear wound was introduced. The medium was removed in the wells and gently washed with Phosphate buffered saline to remove dead/unattached cells. Replenished the wells with 150 μl fresh medium supplemented with 150 μl the of the aqueous extract of seaweeds (The best concentration recorded from above cell viability assay was taken for this experiment). The wound size was observed after 24 h and 48 h incubation. Scratch wound closures were observed using an inverted microscope and digital photograph were taken by a digital camera (Nikon Coolpix 4500; Nikon, Japan). Photographs were analyzed by Carl Zeiss Microscopy GmbH software followed by monitoring the width of the scratch area at 0h, 12h and 24 h time intervals to quantify cell migration ability.

2.6. In-vivo assay {#sec2.6}
------------------

### 2.6.1. Experiment I - wound healing {#sec2.6.1}

#### 2.6.1.1. Dose selection {#sec2.6.1.1}

A pilot dose-response study was conducted to decide the toxic effects of aqueous extracts of selected seaweed species on mice. Doses of aqueous extracts of seaweeds 100 mg/kg BW, 200 mg/kg BW and 400 mg/kg BW were orally administered to mice once daily for 14 days. Animals were observed individually after oral treatment at least once after the first 45 min, periodically after the first 24 h and 48 h for their behavioral changes and stimulations were monitored for 14 days. In the acute toxicity studies, if any behavioral change or mortality and histopathology investigation were detected, the dose administered was assigned as a toxic dose. Therefore, no signs of behavioral changes or mortality were observed by 100, 200 and 400 mg/kg BW doses administered to mice during this initial dose screening *in-vivo* experiment toxicity assay. Therefore, the maximum dose of 400 mg/kg BW of mice was chosen to administer to mice during the *in-vivo* experiments of this study.

#### 2.6.1.2. Experimental animals {#sec2.6.1.2}

Healthy albino mice (BALB/c), total of 36 with average body weight (BW) of 34.79 ± 1.03 g and age of 8 weeks were selected. All the mice were marked and acclimatized for seven days before the experiment. Mice were sheltered separately in individual ventilated cages with the laboratory conditions of temperature regulated at 28 ± 2 °C, humidity (65 ± 5%), with a 12 h light/12 h dark cycle and fed with standard pellet diet and water ad libitum. All the mice were acclimatized for 7 days prior to the study. The study was approved by the Animal Ethics Committee of the Faculty of Veterinary Medicine and Animal Science, University of Peradeniya, Sri Lanka (Ref No. ERC/FVMA/UOP/2013/10), which is on par with the international standards of ethics on animal experimentations.

#### 2.6.1.3. Excision wound model {#sec2.6.1.3}

A full-thickness excision wound was made on general anesthesia by Ketamine (120 mg/kg) ([@bib95]), the shaved dorso-lateral skin with 8 mm Piercing sterile biopsy punch. The shaved skin area was cleaned with 70% ethanol and wounds were created by excising a circular 07.48 ± 0.05 mm diameter portion of the wound area 44.02 ± 0.70 mm^2^. Immediately after wounding, all animals were kept in separate cages with tissue towel beds and fly proof environment by covering of mosquito net. Cage beds were cleaned twice a day with antiseptics (1% Savlon).

#### 2.6.1.4. Treatment of animal {#sec2.6.1.4}

The mice were divided into three different groups (n = 12): Group III; wounds were created and received *S. illicifolium* extracts (400 mg/kg BW/day for 12 days, orally); Group II; wounds were created and received distilled water for 12 days, orally; Group I; normal mice kept intact without wound and any treatment.

#### 2.6.1.5. Measurement of wound contraction and area {#sec2.6.1.5}

The progressive healing changes in all the treatment and control group were measured with a vernier caliper and digital photographs of the wound areas were taken on every three days starting from the first day of wound treatment until the end of the experimental period. The number of days taken for healing of the wound was estimated ([@bib17]) and reduction in the wound area was expressed as percentage of the original wound size ([@bib64]). Changes in wound areas were analyzed and used as an indication of the percentage of wound contraction. It was calculated by using the following formula:(Healed area = Total wound area − Present wound area).

#### 2.6.1.6. Histopathology {#sec2.6.1.6}

A specimen sample of tissue from the healed wound was isolated from treatment and control group of mice and fixed in 10% neutral buffered formalin and dehydrated with a sequence of ethanol-xylene series of solutions, processed and blocked with paraffin at 40-6 °C and sectioned at 3--6 μm in thickness. Paraffin was removed by dehydration and again rehydrated sections were stained with hematoxylin and eosin stain (H & E) for histopathological observations. The wounded tissue sections were assessed for extent of wound contraction, angiogenesis, collagen formation, granulation tissue and epithelization. The progress of epithelization was recorded from the border of normal skin toward the wound center. The microscopic slides were photographed and examined under magnification (40X and 100X).

### 2.6.2. Experiment II - cytokine expression {#sec2.6.2}

#### 2.6.2.1. RNA isolation and amplification {#sec2.6.2.1}

Total RNAs were isolated from the treatment and control wound skin samples using PureLink RNA mini kits (USA) according to the manufacturer\'s instructions. RNA was amplified with random primers as following modifications to inhibit the degradation of RNA by abundant skin RNAases. RNA isolation with potential interference of protein were removed by adding the homogenate in lysis buffer 1 ml with 2-mercaptoethanol 10 μl at room temperature for 3 min and then samples were homogenized using QIAshredder Mini Spin Columns (QIAGEN, USA). Supernatant was recovered and RNA was isolated through a RNeasy mini column with one volumes of chilled ethanol (70%) into a RNase-DNase free tube.

#### 2.6.2.2. cDNA preparation and PCR amplification {#sec2.6.2.2}

The first strand cDNA synthesis was accomplished in 1μl M-MLV Reverse transcriptase (Dongsheng biotech, China) and RNase Inhibitor (Dongshengbiotech, China). Total RNAs of wounded treatment and control mice tissue samples were reverse-transcribed at 70 °C for 5 min in a 20 μl reaction mixture containing mouse Moloney leukemia virus reverse transcriptase (Dongshengbiotech, China) with Random Primers (Dongsheng biotech, China). cDNA was amplified together with specific primers for Tumor Necrosis Factor (TNF-α), Transforming Growth Factor β1 (TGF- β1) and β-actin as control with the primers and conditions mentioned in [Table 2](#tbl2){ref-type="table"}.Table 2Sequences of the primers used for RT-PCR, Transcript Sequence annealing temperature (⁰C), Cycle and Product size (bp).Table 2TranscriptSequenceAnnealing temperature (⁰C)CycleProduc size (bp)**TNF-α**(F) 5-CAGCCTCTTCTCATTCCTGCTTGTG-36035511(R) 5-CTGGAAGACTCCTCCCAGGTATAT-3**TGF-β1**(F) 5-CGGGGCGACCTGGGCACCATCCATGAC-36035405(R) 5-CTGCTCCACCTTGGGCTTGCGACCCAC-3**beta-actin**(F) 5-TTCTACAATGAGCTGCGTGTGGC-36035456(R) 5-CTCATAGCTCTTCTCCAGGGAGGA-3[^1]

Polymerase chain reactions (PCR) were performed in 25 μl of the total volume containing 5×PCR buffer, 25 mM MgCl~2~, 2 mM deoxynucleotide triphosphate (dNTP), 10 μM forward and reverse primers, and Taq DNA polymerase (0.25μl). PCR conditions comprised of an initial denaturation at 95 °C for 5 min followed by 35 cycles of denaturation at 95 °C for 45 s, annealing at 60 °C for 45 s, extension at 72 °C for 1 min and the final extension at 72 °C for 7 min. The PCR products were run on a 2% agarose gel stained with ethidium bromide and subsequently specific bands purified using a gel extraction kit according to the manufacturer\'s instruction (DongshengBiotech, China). The intensities of specific bands were photographed with a charge-coupled device imaging system (Gel Doc.). The specific bands of Purified PCR products were quantified using NanoDrop Spectrophotometers (2000, Termo Scientific, USA). RT-PCR was performed at least three times for each sample and specific PCR products quantify were determined as described above.

### 2.6.3. Experiment III - toxicity study {#sec2.6.3}

After treatment of three mice from each group were sacrificed on the 12^th^, 15^th^, 19^th^ and 26^th^ days of the experimental period. Blood samples were collected to heparin tubes and the serum was separated by centrifugation at 2500 rpm at 4 °C for 10 min for the assessment of biochemical parameters. The Serum enzyme levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatinine levels ([@bib39]) using commercially available human diagnostic test kits (Human Wiesbaden, Germany) according to the manufacturer\'s instructions. The Erba Mannheim spectrophotometer (Model:chem-7, Germany) was used for the serum enzyme measurement. Vital organs of mice (liver, kidney, heart, spleen, and lung) were isolated and weighed. Furthermore, specimens from the organs were collected, examined for any gross changes and preserved for histopathological and toxicological investigations. Behavioral changes, food consumption, and water intake were recorded every three days until the end of the experiment. Body weights of mice have recorded before the starting the experiment and at the end of the experimental period.

2.7. Statistical analysis {#sec2.7}
-------------------------

Prism software package (Graph Pad, Version 4.03; San Diego, CA, USA) for Windows and Excel software were used for all statistical analysis. Lethality concentrations LC~50~ were assessed. ANOVA test was done to find out the significant difference between test extractions and control. Multiple comparisons between the significant levels of interactions of the variables were done by Tukey\'s method. Values were expressed as the Mean ± SEM and P \< 0.05 considered as the presence of statistically significant difference.

3. Results {#sec3}
==========

3.1. Extraction matter concentration analysis {#sec3.1}
---------------------------------------------

Concentration values obtained by the both the methods were more or less the same (see [Table 3](#tbl3){ref-type="table"}).Table 3Concentration (μg/μl) of aqueous seaweed extracts.Table 3Sample NumberSpecies NameConcentration (μg/μl)SW 01*Ulva lactuca*39.08 ± 0.34SW 02*Caulerpa racemosa*43.84 ± 0.21SW 03*Gracilaria corticata*25.80 ± 0.59SW 04*Padina antillarum*27.20 ± 0.64SW 05*Sargassum ilicifolum.*32.08 ± 0.11SW 06*Sargassum polycystem*12.80 ± 0.12SW 07*Halimeda opuntin*07.64 ± 0.09SW 08*Caulerpa racemosa*17.32 ± 0.63SW 09*Turbinaria ornata*23.36 ± 0.38SW 10*Caulerpa sertularioides*17.00 ± 0.22SW 11*Stoechospermum polypodioides*46.84 ± 0.69SW 12*Sargassum ilicifolum.*16.96 ± 0.55SW 13*Sargassum ilicifolum.*60.01 ± 0.35SW 14*Gracilaria corticata*41.12 ± 0.41SW 15*Padina antillarum*36.48 ± 0.63SW 16*Ulva lactuca*95.44 ± 0.33SW 17*Acanthophora spicifera*00.17 ± 0.03SW 18*Gelidiopsis variabilis*14.88 ± 0.46SW 19*Gracilaria corticata*22.84 ± 0.28SW 20*Chaetomorpha antennina*34.04 ± 0.31SW 21*Chaetomorpha crassa*39.08 ± 0.24SW 22*Jania adhaereus*84.20 ± 0.16SW 23*Sargassum ilicifolum*31.16 ± 0.12

3.2. Phytochemical screening of seaweeds {#sec3.2}
----------------------------------------

The seaweeds were technically certified through the identification of the phytochemicals responsible for their use in therapeutic values of health care. The results of qualitative chemical analysis of the aqueous extract of seaweeds are charted in [Table 4](#tbl4){ref-type="table"}.Table 4The results of phytochemical screening of aqueous seaweed extracts.Table 4Sample NumberSpecies NameSaponinsTanninsFlavonoidsAlkaloidsTriterpenesReferencesSW 01*Ulva lactuca*++++\--[@bib68]SW 02*Caulerpa racemosa*++++++-++[@bib46]SW 03*Gracilaria corticata*+++++++++++++[@bib22]SW 04*Padina antillarum*+\-\-\--[@bib9]; [@bib71]SW 05*Sargassum illicifolium*+++++-[@bib69]; [@bib13]SW 06*Sargassum polycystem*+++++-[@bib69]; [@bib56]SW 07*Halimeda opuntin*\--+-+++[@bib49]; [@bib4]SW 08*Caulerpa racemosa*-++++++[@bib46]SW 09*Turbinaria ornata*+++\--[@bib65]; [@bib26]SW 10*Caulerpa sertularioides*\--+-+[@bib100]; [@bib46]SW 11*Stoechospermum polypodioides*++++++[@bib7]SW 12*Sargassum illicifolium*+++++-[@bib69]; [@bib13]SW 13*Sargassum illicifolium*++++-[@bib69]; [@bib13]SW 14*Gracilaria corticata*++++++++[@bib22]SW 15*Padina antillarum*++\-\--[@bib9]; [@bib71]SW 16*Ulva lactuca*++++\--[@bib68]SW 17*Acanthophora spicifera*++++-+[@bib25]SW 18*Gelidiopsis variabilis*-++++-[@bib46]; [@bib79]SW 19*Gracilaria corticata*+++++++[@bib22]SW 20*Chaetomorpha antennina*++++\--[@bib70]; [@bib25]SW 21*Chaetomorpha crassa*+++\--[@bib70]; [@bib43]SW 22*Jania adhaereus*+++++++[@bib36]; [@bib59]SW 23*Sargassum illicifolium*+++++-[@bib69]; [@bib13][^2]

3.3. Brine shrimp assay {#sec3.3}
-----------------------

The crude extracts of *Sargassum polycystum* (SW06; 12.80 μg/μl), *Turbinaria ornate* (SW09; 23.36 μg/μl), *Sargassum illicifolium* (SW13; 16.96 μg/μl), *Padina antillarum* (SW15; 36.48 μg/μl), *Gelidiopsis variabilis* (SW18; 14.88 μg/μl), *Gracilaria corticata* (SW19; 22.84 μg/μl), *Chaetomorpha antennina* (SW20; 34.04 μg/μl), *Chaetomorpha crassa* (SW21; 39.08 μg/μl) and *Sargasum illicifolium* (SW23; 31.16 μg/μl) showed 100% mortality of brine shrimp nauplii followed by 24 h incubation. Moreover, the crude extracts of *Gracilaria corticata* (SW14; 41.12 μg/μl), *Acanthophora spicifera* (SW17; 0.20 μg/μl) and *Jania adhaerens* (SW22; 84.2 μg/μl) exhibited a remarkable toxic effect of brine shrimp nauplii after 2 h of incubation period (see [Table 5](#tbl5){ref-type="table"}).Table 5LC~50~ values in μg/μl of aqueous extracts of different seaweed samples after incubation for 24 h. 50% lethal concentration for brine shrimp nauplii was considered as LC~50~ value.Table 5Voucher number and speciesLC~50~ value (μg/μl)Voucher number and speciesLC~50~ value (μg/μl)SW01;*Ulva lactuca*49.71SW13;*Sargassum illicifolium*7.63SW02;*Caulerpa racemosa*-SW14;*Gracilaria corticata*4.93SW03;*Gracilaria corticata*12.93SW15;*Padina antillarum*16.05SW04;*Padina antillarum*-SW16;*Ulva lactuca*-SW05;*Sargassum illicifolium*18.43SW17;*Acanthophora spicifera*0.03SW06;*Sargassum polycystem*5.76SW18;*Gelidiopsis variabilis*9.74SW07;*Halimeda opuntin*37.6SW19;*Gracilaria corticata*1.91SW08;*Caulerpa racemosa*-SW20;*Chaetomorpha antennina*16.7SW09;*Turbinaria ornata*3.89SW21;*Chaetomorpha crassa*21SW10;*Caulerpa sertularioides*-SW22;*Jania adhaereus*10.06SW11;*Stoechospermum polypodioides*-SW23;*Sargasum illicifolium*9.93SW12;*Sargassum illicifolium*5.30

All tested seaweed species have shown concentration dependent mortality of brine shrimp nauplii after 24 h incubation. Collectively all red seaweed species showed significantly low LC~50~ values compared with all other tested brown and green seaweed samples. *Ulva lactuca* collected from Negombo (North-western coastal area) showed the highest LC~50~ value out of all green seaweed samples.

3.4. *In-vitro* assay {#sec3.4}
---------------------

Most of the tested aqueous seaweed extracts did not appear significant cytotoxic effect on L929 cells. Based on the results, cell proliferation and migration activity were observed in the wells with L929 cell line treated with most of the aqueous extracts of brown seaweeds. Furthermore, almost all tested aqueous extracts of Green, Brown and Red seaweed samples, except Red algae *Jania adhaereus* (SW22), did not show a significant cytotoxic effect on L929 cells (see [Figure 3](#fig3){ref-type="fig"} & [Figure 4](#fig4){ref-type="fig"}).Figure 3L929 cell viability and proliferation percentage against aqueous extracts of seaweed samples after 24 h incubation. A; Cell viability is given as a percentage with compared to the control test. B; L929 cell proliferation observed as a percentage of the scratch wound close area compared to the control test. SW01-*Ulva lactuca*; 19.54 μg/μl, SW02-*Caulerpa racemose*; 5.48 μg/μl, SW03-*Gracilaria corticata*; 6.45 μg/μl, SW04-*Padina antillarum*; 13.60 μg/μl, SW05-*Sargassum illicifolium*; 16.04 μg/μl, SW06-*Sargassum polycystem*; 6.40 μg/μl, SW07-*Halimeda opuntin*; 3.82 μg/μl, SW08-*Caulerpa racemose*; 8.66 μg/μl, SW09-*Turbinaria ornate*; 11.68 μg/μl, SW10-*Caulerpa sertularioides*; 8.50 μg/μl, SW11-*Stoechospermum polypodioides*; 5.86 μg/μl, SW14-*Gracilaria corticata*; 20.56 μg/μl, SW15-*Padina antillarum*; 18.24 μg/μl, SW16-*Ulva lactuca*; 47.72 μg/μl, SW17-*Acanthophora spicifera*; 0.10 μg/μl, SW18-*Gelidiopsis variabilis*; 7.44 μg/μl, SW19-*Gracilaria corticata*; 11.42 μg/μl, SW20-*Chaetomorpha antennina*; 17.02 μg/μl, SW21-*Chaetomorpha crassa*; 9.77 μg/μl, SW22-*Jania adhaereus*; 42.10 μg/μl, All values are expressed as mean±SEM (n=08). One-way analysis of variance (ANOVA) Tukey's comparisons test. ∗indicates comparison with the Control, ∗p\<0.05.Figure 3Figure 4The migration and proliferation ability on L929 cells against the seaweed extracts. Microscopic inspection (40×magnifications) at 12 h and 24 h of scratch wound healing. SW01-*Ulva faciata*, SW02-*Caulerpa racemosa*, SW03-*Gracilaria corticata*, SW04-*Padina antillarum*, SW05-*Sargassum illicifolium*, SW06-*Sargassum polycystem,* SW07-*Halimeda opuntin,* SW08-*Caulerpa racemosa*, SW09-*Turbinaria ornata*, SW10-*Caulerpa sertularioides*, SW11-*Stoechospermum polypodioides,* SW14-*Gracilaria corticata*, SW15-*Padina antillarum,* SW16-*Ulva lactuca*, SW17-*Acanthophora spicifera,* SW18-*Gelidiopsis variabilis,* SW19-*Gracilaria corticata*, SW20-*Chaetomorpha antennina*, SW21-*Chaetomorpha crassa*,SW22-*Jania adhaereus.* Cell proliferation is given as a percentage compared to the control test. All values are expressed as mean ± SEM (n = 08). One-way analysis of variance (ANOVA) Tukey\'s comparisons test. ∗indicates significantly difference with Control, *∗*p \< 0.05.Figure 4

3.5. *In-vivo* assay {#sec3.5}
--------------------

### 3.5.1. Wound healing {#sec3.5.1}

The progressive healing changes in wounds of mice from each group during the experiment are presented below.

The rates of wound contraction were expressed as a percentage (%) of healed wound area ([Table 6](#tbl6){ref-type="table"}).Table 6Wound healing area % (mm^2^) of each test group over a period of 12 days.Table 6DayControlTreatment0143.75 ± 02.2144.70 ± 00.430326.29 ± 02.4217.35 ± 01.94^a^∗0615.12 ± 02.4807.71 ± 01.15^a^∗0902.92 ± 00.7600.06 ± 00.02^a^∗1200.00 ± 00.0000.00 ± 00.00[^3]

There was a significant difference (p \< 0.05) in wound closure between the control and treatment group on the 3^rd^ and 6^th^ and 9^th^ day. *S. illicifolium* extracts exhibited a significantly enhanced wound healing activity in mice group III within three days (p \< 0.05) with open wound area of 17.35 ± 1.94 mm^2^ compared with control group 26.29 ± 2.42 mm^2^. On day 6^th^, the treatment group and control group had an open wound area of 7.70 ± 1.15 mm^2^ and 15.12 ± 2.48 mm^2^, respectively. On day 9^th^, treatment group and the control group had an open wound area of 0.058 ± 0.022 mm^2^ and 2.92 ± 0.76 mm^2^, respectively. On the 12^th^ day the wound area of treatment group mice was completely healed and epithelialized (see [Figure 5](#fig5){ref-type="fig"}).Figure 5Changes in wound area at each time point to the original wound area of mice in control and treatment group over a period of 12 days. A; Wound healing area (mm^2^) of test groups, B; Wound healing percentages (%) of test and control groups, C; Digital photographs of mice showing various stages of wound healing. Day 0 picture was taken immediately after injury. Values of diameter of wounds are expressed as mean ± SEM (n = 12). a = when compared with control group, (∗) indicates statistically significant difference from respective group using ANOVA, followed by Tukey\'s comparisons test (p \> 0.05). (†) indicates statistically no significant difference from respective group using ANOVA, followed by Tukey\'s comparisons test (p \> 0.05). Control group received an equal volume of distilled water, orally; untreated wounds and Treatment group received *S. illicifolium* extracts (400 mg/kg BW/day for 12 days, orally).Figure 5

The extracts of *S. illicifolium* showed the highest level of wound healing activity within three days (61.20%) compared with the control group (39.91%).

### 3.5.2. Hitopathological changes {#sec3.5.2}

In the treatment group, 82.75% of the original wound area healed within 6 days after injury, with angiogenesis and collagen accumulation. The renewed epidermis had enclosed the wound area completely at the 9^th^ day of *S. illicifolium* treatment group. Primitive degree of granular tissue formation was reported in the control group, but there were no differentiated epidermal layers compered to treatment group.

Images were taken with a microscope facilitated with a camera (×40 and ×100 magnifications) (Carl Zeiss Microscopy, Germany). Histopathological findings showed that the aqueous extract of *S. illicifolium* has enhanced the tissue granulation and re-epithelization significantly compared with the control group. *S. illicifolium* extracts treatment resulted decrease in inflammation, increase in the rate of tissue proliferation as well as remodeling, and reepithelization ([Figure 6](#fig6){ref-type="fig"}).Figure 6Photomicrographs epidermis sections of wound tissues; hematoxylin and eosin stain staining (H & E; 40 and 100). A; Histopathological skin sections determine the changes in wound healing events B; Granulation tissue of the wounded skin. Arrows pointing events during wound healing; s, scab; re, re- epithelialization; IC, inflammatory cells; nv, neovascularization, GT: granulation tissue, mnc: mononuclear; F: fibroblasts; CF: collagen fiber, NE: new epithelium. Control (C): received an equal volume of distilled water, orally; untreated wounds, Treatment (T): received S. illicifolium extracts (400 mg/kg BW/day for 12 days, orally).Figure 6

### 3.5.3. Cytokine expression {#sec3.5.3}

RT-PCR analysis showed the high level of TGF-β expression in *S. illicifolium* treated wound skin at 6 days. The lowest level of TNF-α expression shown in *S. illicifolium* treated wound skin when compared with control group during the healing process. Equal level of β-Actin expression were seen in *S*. *illicifolium* treated wound skin and control. β-Actin expression did not indicate any significant difference in treatment and control wounded skin. TGF-β and TNF-α expression were significantly different during the healing process of wound tissue between treatment and control groups (see [Figure 7](#fig7){ref-type="fig"}).Figure 7RT-PCR analysis for mRNA expression of mice wound tissue samples over a period of 12th days. A; TGF-β expression during the wound healing of treatment and control (Ratios of TGF-β on 3,6,9 and 12 days post injury treatment and control). B; TNF-α expression during the wound healing of treatment and control (Ratios of TNF-α on 3,6,9 and 12 days post injury treatment I and control). C; β-Actin expression during the wound healing of treatment and control (Ratios of β-Actin on 3,6,9 and 12 days post injury treatment I and control). Control: Wound were created and received an equal volume of distilled water, orally, Treatment: Wound were created and *received S. illicifolium* extracts (400 mg/kg BW/day for 14 days, orally). Values are expressed as mean ± SEM (n = 4 animals); Data is compared against control group. One way analysis of variance (ANOVA) Tukey-Kramer multiple comparisons test ∗p \< 0.05. 3T--3 Day Treatment, 3C- 3 Day Control, 6T - 6 Day Treatment, 6C - 6 Day Control, 9T - 9 Day Treatment, 9C - 9 Day Control, 12T - 12 Day Treatment, 12C - 12 Day Control, N -- Negative Control, L - Ladder. Full, non-adjusted images of RT-PCR blots include in Supplementary Figure 1.Figure 7

### 3.5.4. Toxicity study {#sec3.5.4}

#### 3.5.4.1. Body weight and behaviour changes {#sec3.5.4.1}

Although the mice in treatment group showed the highest body weight compared to the control groups there was no significant difference between the treatment group and the control groups. The animals were physically active and were consuming food and water in a regular way.

#### 3.5.4.2. Biochemical parameters {#sec3.5.4.2}

Toxicity studies of the seaweeds extracts showed no signs and symptoms such as restlessness, respiratory distress, diarrhea, convulsions, and coma and it was found safe at 400 mg/kg dosage. Studied biochemical parameters for the toxicity assessment; serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and serum creatinine levels of mice in each group are given below (see [Figure 8](#fig8){ref-type="fig"}).Figure 8Biochemical values of mice of each test group over a period of the 26^th^ day. A; Serum aspartate aminotransferase (AST) levels in mice, B; Alanine aminotransferase (ALT) levels in mice, C; Serum creatinine levels in mice. Data are expressed as mean ± SEM (n = 12 mice); Data is compared against control group. a = when compared with control group, b = when compared with treatment II Group, (∗) indicates statistically significant difference from respective group using ANOVA, followed by Tukey\'s comparisons test (p \> 0.05). (†) indicates statistically no significant difference from respective group using ANOVA, followed by Tukey\'s comparisons test (p \> 0.05). Control group received an equal volume of distilled water, orally; untreated wounds and Treatment group received *S. illicifolium* extracts (400 mg/kg BW/day for 12 days, orally).Figure 8

The biochemical parameters that were analyzed in this experiment groups were compared between experimental groups, such as the Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and serum creatinine, levels not exhibit significant different from their normal ranges (AST/SGOT: 54--98 IU/L, ALT/SGPT: 17--77 IU/L, Serum Creatinine; 0.2--0.9 mg/dl for laboratory mice, research animal resources, University of Minnesota) in all three groups.

These results indicated the fact that mice vital organs have not any considerable damage due to the feeding of experimental seaweeds extracts.

#### 3.5.4.3. Histopathological sections of vital organ {#sec3.5.4.3}

Histopathological sections of vital organs of mice of each treatment group for day 12^th^, day 15^th^, day 19^th^, and day 26^th^ days exhibited normal histology compared with control groups. No considerable morphological changes were observed in sections of vital organs. Normal morphology of vital organs provided strong evidence for safety and non-toxic effects of ingestion of S. *illicifolium*. These results indicated the fact that vital organs have not any considerable damage due to *S*. *illicifolium* extract administrated orally as the time period (see [Figure 9](#fig8){ref-type="fig"}).Figure 9Histopathological sections of heart, liver, lungs, spleen, and kidney in mice treated with seaweed extracts and the control. Vital organs of mice stained with hematoxylin and eosin stain (H & E; 40×). Control (C): received an equal volume of distilled water, orally, Treatment (T): received *S. illicifolium* extracts (400 mg/kg BW/day for 12 days, orally).Figure 9

4. Discussion {#sec4}
=============

Among the natural marine resources, seaweeds are considered as a rich source of natural bioactive compounds ([@bib101]). It is reported that more than 2400 marine natural compounds had been isolated from seaweeds present in subtropical and tropical worldwide algal beds ([@bib51], [@bib52], [@bib53]). For a long time, human beings have used marine algae as food supplements and medicines because seaweeds are a great source of pharmacologically active metabolites with antineoplastic, antimicrobial, antiviral ([@bib28]; [@bib94]) and antitumor activities ([@bib55]). Also, those active compounds have shown potential immune stimulant activity as well ([@bib41]). In Sri Lanka, there are sandy and rocky coastal regions where algal species are distributed copiously ([@bib76]).

In the present study aqueous extracts of twenty-three different seaweed species collected from different coastal sites in Sri Lanka showed promising wound healing activity *in-vitro* and *in-vivo*. Phytochemical compounds present in selected samples were also investigated and the seaweeds samples contained natural phytochemicals such as saponins, flavonoids, tannins, alkaloids and triterpenes. The result of qualitative chemical analysis of the aqueous extract of seaweeds and references reported in literature are tabulated in [Table 4](#tbl4){ref-type="table"}. Moreover, during the phtochemical analysis, saponins, flavonoids, tannins, alkaloids and triterpenes were reported in the most of the aqueous extracts of red and brown seaweed samples compared with green seaweed samples. In this context, saponins, flavonoids, tannis, akaloid and terpenoids were mainly recorded in aqueous extracts of *Gracilaria corticata*. Flavonoids, tannins, alkaloids and triterpenes were absent in aqueous extracts of *Padina antillarum* and triterpene was totally absent in aqueous extracts of *Sargassum* species and *Ulva lactuca* but present in the aqueous extracts of *Halimeda opuntin*, *Caulerpa racemosa* and *Caulerpa sertularioide*. Flavonoids were observed in aqueous extracts of all the seaweeds except aqueous extract of *Padina antillarum*. Recent reports of antiviral, anti-fungal, antioxidant, anti-inflammatory, antiallergenic, anti-thrombic, anti-carcinogenic, hepatoprotective and cytotoxic activities of flavonoids have been generated an interest on studies regarding flavonoid containing plants ([@bib97]; [@bib35]) and these flavonoids are considered as a natural drug which possess numerous promising biological and pharmacological importance. Aqueous extracts of *Gracilaria corticata* reported the highest amount of alkaloids compared with other seaweed extracts and alkaloids were absent in *Ulva fasciata*. Many reports revealed the presence of alkaloids in seaweeds and some of seaweed species have been investigated for their biological activities as well ([@bib2]). Alkaloids are commonly found to have antimicrobial properties ([@bib106]) against both gram-positive and gram-negative bacteria ([@bib45]). During this study saponins were detected in all the aqueous extracts of red seaweeds and green seaweed; *Ulva lactuca*. Saponins had showed numerous biological properties including antimicrobial, anti-inflammatory, anti-feedent and haemolytic effects ([@bib109]). The highest amount of tannins was recorded in the aqueous extracts of *Caulerpa racemosa* out of other green seaweed extracts. The results of the phytochemical investigation of seaweeds revealed the presence of various secondary metabolites in a varied degree. Recently, many studies have been conducted on the phytochemistry of seaweeds worldwide ([@bib86]; [@bib29], Somepalli et al., 2007; [@bib2]). It suggests that seaweeds have a great medicinal value and have been extensively used in the pharmaceutical industry. Based on the literature, the environmental conditions and geographical distribution like factors including light, water temperature, salinity, nutrients, minerals availability may effect on the chemical composition of marine algal and seagrass species ([@bib78]).

The brine shrimp lethality assay is very important as a preliminary toxicity screening of any biological compound or product since it is a comparatively easy and cheap method which provides the basic information useful to extend further cytotoxicity tests; *in-vitro* or *in-vivo* though a few of the studies have been carried out to check the cytotoxicity of seaweeds using brine shrimp test ([@bib110]). Toxicity index values (LC~50~) of extracts are used to find out whether the extracts are toxic or non-toxic. If LC~50~ value of an extract is greater than 1 mg/ml that extract is considered as a non-toxic extract (Meyer et al., 1982 and [@bib18]). LC~50~ values of the most of samples were greater than 1 mg/ml and considered as non-toxic whereas SW17-*Acanthophora spicifera* (LC~50~ = 0.033 μg/μl) was the only species that exhibited toxic results in brine shrimp lethality assay. Since LC~50~ value of SW17 was in between 0-100 μg/ml that species is considered as a highly toxic species which is compatible with studies of [@bib18]. It was observed that even the lowest tested concentration of *Acanthophora spicifera,* (0.20 μg/μl) was detrimental to brine shrimp nauplii. This inhibitory effect of the extract might be due to any toxic compound present in the active fraction that possesses ovicidal and larvicidal properties. According to the [@bib34] and [@bib108], cytotoxic potency of a natural extract is considered as a clue for the presence of antitumor compounds. The cytotoxic property of plant materials are due to the presence of antitumor compounds ([@bib8]) and many of the secondary metabolites produced by the marine red algae are well known for their cytotoxic property ([@bib114]). Further, the crude extracts or any tested concentrations of green seaweed species *Caulerpa racemosa* (SW02, 43.84 μg/μl), *Halimeda opuntia* (SW07, 7.64 μg/μl), *Caulerpa racemosa* (SW08, 17.32 μg/μl), *Caulerpa sertularioides* (SW10, 17.00 μg/μl) and *Ulva lactuca* (SW16, 95.44 μg/μl) did not exhibit any abnormal behavior or mortality during the study period. The present study indicated that the brine shrimp lethality assay is a reliable method for the assessment of toxic effect of seaweeds and lends support for the further studies. The aqueous extracts red and brown seaweed showed brine shrimp larvicidal activity and the degree of lethality is directly proportional to the concentration of the extracts. Based on the results, the brine shrimp lethality of the seaweed extracts were found to be concentration dependent. The observed lethality of the seaweed extracts on brine shrimps indicated the presence of potent cytotoxic components of seaweeds.

The MTT assay was carried out using living, metabolically active cells to assess cell viability and proliferation followed by treating the cells with different concentrations of testing extracts. The absorbance value from the MTT assay is directly proportional to the viable cell count of the respective well ([@bib61]). In this study, cytotoxic effect of the aqueous seaweed extracts have been compared with the negative control and other seaweed extract treated cells. The highest cytotoxicity against L929 cell line was recorded by *Jania adhaereus* (red algae) extract (42.10 μg/μl concentration) and it accounts for 50.70 ± 7.304% cell growth inhibition. Cell viability and proliferation activity have increased with the increase of the concentration of many seaweeds extracts. In this context, a promising cell proliferation was recorded in the wells treated with *Padina antillarum* (SW15, 431.5 ± 41.13%). The morphology of the treated cells does not show any variation when compared with the control cells. Moreover, seaweed extracts of *Stoechospermum polypodioides* (SW15; 5.86 μg/μl) and *Gelidiopsis variabilis* (SW18, 7.44 μg/μl) have also shown a potential cell proliferation activity on L929 cell line. Therefore, phytochemical compounds reported in afore mentioned seaweed extracts could be responsible for the cell proliferation and wound healing activity exhibited during this study. This study provides only basic data regarding induction of epithelial cell proliferation and further studies are necessary for isolation and identification of biological active substances of these extracts responsible for wound healing activity. When comparing the cell proliferation or/and migration effect of the aqueous extract of *Halimeda opuntin* and *Stoechospermum polypodioides* with all other seaweed extracts on L929 cell line, *Halimeda opuntin* be considered as a potential source of bioactive compounds which are having wound healing properties. According to previous study results, even the lowest concentration of *Sargassum* species has showed greater effect on cell proliferation and migration compared to the control group ([@bib75]). Thus *in-vitro* assays indicate that the aqueous extracts of most of the selected seaweeds possess significant wound healing properties which might be helpful in healing of various wounds in animals. This also infers that all the seaweeds are comprised of potent wound healing agents, specifically seaweed could be a potential candidate for wound healing therapy in near future. All the tested seaweed species except *J. adhaereus* did not show any significant cytotoxic effect compared to control group. Therefore, this result suggests that the bioactive compounds of these seaweed species can be isolated and can be used for further medicinal investigations including wound healing activity.

The wound healing process of repairing the skin injury is a dynamic, complex, and well-organized process ([@bib80]). Assessment of cell migration activity of epithelial cells towards the wounded area is necessary during the investigation of wound healing potential of any biological resource. The *in vitro* scratch assay is considered one of the earliest developed, an easy and comparatively low-cost methods used to assess directional cell migration ([@bib47]). It has been widely used for gene knockdown or chemical exposure. In general, cell migration activity of cells treated with *S. illicifolium* extracts (0.97 μg/μl, 97.83 ± 0.05%) ([@bib75]) and *Halimeda opuntin* extracts (SW11; 3.82 μg/μl, 91.63 ± 0.28) showed highest cell migration ability compared with other seaweeds extracts and control groups. Aqueous extracts of *J*. *adhaereus* (SW22, 42.10 μg/μl, 00.60 ± 0.07%) (Mean ± SEM, n = 08) (P \> 0.05) showed significant cytotoxic effect compared with other seaweed extracts and control.

Mammalian wound healing activity is a kind of complex process mainly occurs due to cell migration and proliferation and it aligns with various systematized cellular activities. The wound repair in multicellular organisms is a process by which a damaged skin or tissue is restored to its normal state by forming several layers to cover the wound. Wound healing mainly depends on the repairing ability of the wounded tissue, the extent of damage and the general health state of the wounded tissue. The normal healing cascade begins with an orderly process of hemostasis and fibrin deposition, which leads to an inflammatory cell cascade, characterized by neutrophils macrophages and lymphocytes within the tissue ([@bib54]). At the end of healing, the number of inflammatory cell decreases and the fibroblast cell increases. The fibroblast cell in connective tissue which produces collagen and other fibres are needed to repair the tissue injury ([@bib83]). In the tissue repair process, inflammatory cells promote the migration and proliferation of endothelial cells leading to neovascularization of connective tissue cells which synthesize extracellular matrices including collagen resulting in re-epithelialization of wounded tissue ([@bib87]). In the present study, it is revealed that in the excision wound model, mice fed with aqueous extracts of *S. illicifolium* (SW23; 400 mg/kg) showed a significant increase in wound healing process than that of the control. This might be due to the activity; one or more bioactive compounds present in the tested seaweeds extracts on the wound healing process and it may have enhanced the activity at certain phase in the wound healing process. Histopathological findings revealed that the healing process was significantly fast in the mice group that treated orally with *S*. *illicifolium* extract (SW23; 400 mg/kg). The histopathological sections proved that the content of the granulation tissue, the rate of wound contraction and epithelialization in the tissue sections taken from the animal group treated orally with *S. illicifolium* extracts was significantly increased compared to the control group.

Enhanced healing activity may also be attributed to increased synthesis of collagen accumulates and angiogenesis ([@bib30]; [@bib31]). Angiogenesis helps to improve granulation of tissues by providing good blood supply to the injury site, thus provides adequate amount of required nutrients and oxygen for the healing process ([@bib3]). Wound healing involves regeneration of specialized cells by the proliferation of surviving cells and connective tissue response characterized by the formation of granulation tissue ([@bib107]). Thus, the effect of *S*. *illicifolium* on wound contraction and epithelialization reported during this study suggests that aqueous extracts of *S*. *illicifolium* may contain bioactive compound which has the ability to enhance epithelial cell migration, proliferation and the action of myofibroblasts. In this context, the decrease in the diameter of the whole wound was determined as the wound contraction, for the easiness of differentiation of wound contraction from re-epithelialization process. Further, brown seaweed possesses alginates, polysaccharides, laminarin, fucoidan, cellulose, mannitol, galactans and fucans, ([@bib50]). Fucoidans has been reported an effect on the inflammatory activity and antioxidant properties ([@bib104]). Nevertheless, the non-halogenated and halogenated terpenoids in the seaweeds ([@bib37]) might also be directly involve to wound healing process. Therefore, the factors mentioned above could be responsible for the wound healing activity exhibited by the aqueous extracts of *S*. *illicifolium* during this study.

*In-vivo* toxicity findings of this study showed that there is no toxic effect from the *S. illicifolium* aqueous extracts (400 mg/kg) on mice ([Figure 8](#fig8){ref-type="fig"}). Changes in organ weight are considered as a sensitive indicator. Therefore, the comparison of organ weight of treatment group with the control group was carried out to estimate the toxic effects in toxicological studies ([@bib57]; [@bib85]). There was no significant difference of mean weight of all the vital organs between the treatment group and control groups. Moreover, biochemical methods such as serum ALT/AST analysis are also used to estimate the toxic effect of any chemical or a treatment. In general, levels of serum enzymes; ALT and AST tend to increase significantly, If the liver cells got impaired due to influence of the introduction of infectious agents, chemicals or any other causative agents ([@bib19]). Based on that, the serum ALT and ASL levels of mice of treatment group and control groups were investigated and such condition was not observed in in any group of mice. In toxicological studies, the liver and kidneys are considered as vital organs thus are widely used to test possible toxic effects due to ingested toxins in experimental trials ([@bib5]).

The expression of TGF-β is very important as inflammatory mediators in scar less wound repair. Overexpression of TGF-β in mice dermal wound healing would create an accelerated scarless wound healing. Also, TNF-α expression mediated signals have a role in promoting leukocyte infiltration at the wound site and negatively affect on wound healing, probably by reducing angiogenesis and collagen accumulation ([@bib60]). In the current experiment, wound healing activity was evaluated in the injured tissue specimens collected from control and treatment based on TGF-β and TNF-α expression. However, an acceleration of wound healing was observed and similarly, a significant upregulation of TGF-β expression levels at three to six days after injury was also recorded in the treatment group compared with the control group. The level of TGF-β expression returns near baseline level after reepithelialization because TGF-β plays a significant role during the process of reepithelialization which begins around day 6 in wounded mice. The higher expression level of TNF-α is related to the inhibition of wound reepithelialization. Further, low levels of TNF-α promote wound healing by indirectly stimulating inflammation and accelerate the wound healing process. The results of the current study showed low expression levels of TNF-α at 6 days after injury in the treatment group compared to the control groups. However, TNF-α expression was significantly increased after 6^th^ day of injury in the wound tissues of mice in control group due to prolonged period of time indicated wound healing delay. The expression of TGF-β and suppression of TNF-α at 6 days appears to coincide with the proliferative phase of wound repair in injured treatment mice wounds. It has been proposed that the cellular infiltrate present on the treatment mice group at day 6 is likely a combination of inflammatory cells and fibroblasts. Specifically, more collagen have been increasingly observed in wound tissue at early 6 days after injury in wound site of treated mice compared with control mice. *S*. *illicifolium* treated mice has been shown considerably higher epithelial gaps when compared to the control animals at 6^th^ days after injury and the epithelial thickness was significantly decreased at these time points.

The TGF-β consist in the granulation tissue was expected to be essential for effectual healing because TGF-β stimulates angiogenesis, fibroblast proliferation, myofibroblast differentiation and matrix deposition ([@bib23]; [@bib81]; [@bib82]). However, wounds of the treatment and control group were completely reepithelialized at 12^th^ day of post-wounding. Comparatively, excision wounds healed due to granulation tissue formation and reepithelialization were distinguishable in the wound of mice in treatment and control groups. This finding is supported by a various types of studies in animal models that confirmed a convenient effect of exogenous TGF-β for wound restoration; the rate of healing and strength of the wound healed ([@bib5]). These data suggest the role of TGF-β compensated during healing engaged by formation of granulation tissue. These results represent the significance of the excision wounds for the investigation of growth factors in wound healing. Therefore, TGF-β is involved in the turnover of the wound healing process directly, it would be necessary for future experiments to examine how seaweeds extracts influence on TGF-β cytokine expression after injury. Additionally, TNF-α is suppressed during wound healing process thus, it would also be necessary to investigate the role of cytokines in both the expression and suppression through the wound healing.

Therefore, further studies are required to determine and isolate bio-active compound(s); from these seaweeds with therapeutic value. The findings of this study would provide baseline information on the cytotoxicity of the tested seaweed species that could be used in further studies in the investigation of their bioactive compounds and potential therapeutic uses. In additional, some other studies using bio-active compound(s) of *S*. *illicifolium* are required to appreciate the complete the wound healing mechanism. Indeed, studies are required to evaluate longer post-injury time points for stabilization of TGF-β and TNF-α mRNA in pre-injury levels. Further research on these species will enable thorough understanding of the therapeutic value through isolation of bioactive compounds.

5. Conclusion {#sec5}
=============

The examined seaweed species could be collected and utilized effectively in product preparation that will be beneficial to the mankind. Phytochemicals as flavonoids and alkaloids were exceptionally present in *Gracilaria corticata*. This species can be further worked out to extract their active metabolites. Brine shrimp lethality assay was conducted to investigate cytotoxicity of aqueous seaweed extracts. Green seaweed species *Caulerpa racemosa* and *Caulerpa sertularioides* and brown seaweed species *Padina antillarum* did not exhibit mortality within tested concentrations. Crude extracts of brown and red seaweeds species have shown thigh mortality rate compared to green seaweeds. In additional, remarkable cytotoxic effect on L929 cell line was exhibited by one of the red seaweed named; *Jania adherens* when compared to the control. Extract of *Halimeda opuntin* and *Stoechospermum polypodioides* has properties that render it capable of promoting accelerated scratch wound healing activity compared with control and other seaweeds species. The final conclusion of the study was that *Sargassum ilicifolum* as a candidate for more studies on *in-vivo* wound healing evaluation would provide great insight for its potential. Histopathological findings also revealed that healing process was significantly fast in the mice group treated with *Sargassum ilicifolum* aqueous extracts by enhancing epithelialization and stimulating tissue proliferation. Also the results of this current study clearly indicated that the continuous oral administration of *Sargassum illicifolium* aqueous extracts in experimental mice up to 400 mg/kg dosage do not exert any acute/sub-acute toxic effect. Therefore, this seaweed source has wound healing properties and it does not show any toxic effect on mice. It can be a new marine resource for wound medicine and to demonstrate that marine algae can be a potential candidate sources as wound drugs. However, further investigations should be conducted to elucidate the mechanisms of action of the *Sargassum illicifolium* extracts, expanding the knowledge of healing process. This also infers the seaweeds are potent anticancer agents, specifically *Jania adhaereus* could be a potential candidate for cancer therapy in the near future. Further research studies are being carried out on those species of seaweeds from the same habitat in order to provide complete data on the nutritive and medicinal potential of these plants.
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[^1]: \(F\) Forward primer, (R) reverse primer.

[^2]: \+ Present; - Absent.

[^3]: Data are expressed as values: mean ± SE (n = 12) and analyzed by two-way analysis of variance. ∗p \< 0.05 when compared to control group animals. *a* = when compared with control group, (*∗*) indicates statistically significant difference from respective group using ANOVA, followed by Tukey\'s comparisons test (p \> 0.05). (†) indicates statistically no significant difference from respective group using ANOVA, followed by Tukey\'s comparisons test (p \> 0.05). Control group received an equal volume of distilled water, orally; untreated wounds and Treatment group received *S. illicifolium* extracts (400 mg/kg BW/day for 14 days, orally).
